Skip to main content
Erschienen in: European Journal of Nutrition 2/2018

19.12.2016 | Original Contribution

Absolute versus relative measures of plasma fatty acids and health outcomes: example of phospholipid omega-3 and omega-6 fatty acids and all-cause mortality in women

verfasst von: Kyoko Miura, Maria Celia B. Hughes, Jacobus P. J. Ungerer, David D. Smith, Adèle C. Green

Erschienen in: European Journal of Nutrition | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In a well-characterised community-based prospective study, we aimed to systematically assess the differences in associations of plasma omega-3 and omega-6 fatty acid (FA) status with all-cause mortality when plasma FA status is expressed in absolute concentrations versus relative levels.

Methods

In a community sample of 564 women aged 25–75 years in Queensland, Australia, baseline plasma phospholipid FA levels were measured using gas chromatography. Specific FAs analysed were eicosapentaenoic acid, docosapentaenoic acid, docosahexaenoic acid, total long-chain omega-3 FAs, linoleic acid, arachidonic acid, and total omega-6 FAs. Levels of each FA were expressed in absolute amounts (µg/mL) and relative levels (% of total FAs) and divided into thirds. Deaths were monitored for 17 years and hazard ratios and 95% confidence intervals calculated to assess risk of death according to absolute versus relative plasma FA levels.

Result

In total 81 (14%) women died during follow-up. Agreement between absolute and relative measures of plasma FAs was higher in omega-3 than omega-6 FAs. The results of multivariate analyses for risk of all-cause mortality were generally similar with risk tending to inverse associations with plasma phospholipid omega-3 FAs and no association with omega-6 FAs. Sensitivity analyses examining effects of age and presence of serious medical conditions on risk of mortality did not alter findings.

Conclusions

The directions and magnitude of associations with mortality of absolute versus relative FA levels were comparable. However, plasma FA expressed as absolute concentrations may be preferred for ease of comparison and since relative units can be deduced from absolute units.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F (2012) Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. Br J Nutr 107(SupplementS2):S201–S213. doi:10.1017/S0007114512001596 CrossRef Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F (2012) Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. Br J Nutr 107(SupplementS2):S201–S213. doi:10.​1017/​S000711451200159​6 CrossRef
2.
Zurück zum Zitat Wu JH, Lemaitre RN, King IB, Song X, Psaty BM, Siscovick DS, Mozaffarian D (2014) Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study. Circulation 130:1245–1253. doi:10.1161/circulationaha.114.011590 CrossRef Wu JH, Lemaitre RN, King IB, Song X, Psaty BM, Siscovick DS, Mozaffarian D (2014) Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study. Circulation 130:1245–1253. doi:10.​1161/​circulationaha.​114.​011590 CrossRef
6.
Zurück zum Zitat Fekete K, Marosvölgyi T, Jakobik V, Decsi T (2009) Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review. Am J Clin Nutr 89(6):2070S–2084S. doi:10.3945/ajcn.2009.27230I CrossRef Fekete K, Marosvölgyi T, Jakobik V, Decsi T (2009) Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review. Am J Clin Nutr 89(6):2070S–2084S. doi:10.​3945/​ajcn.​2009.​27230I CrossRef
9.
Zurück zum Zitat Arab L (2003) Biomarkers of fat and fatty acid intake. J Nutr 133(3):925S–932SCrossRef Arab L (2003) Biomarkers of fat and fatty acid intake. J Nutr 133(3):925S–932SCrossRef
10.
Zurück zum Zitat Schwertner HA, Mosser EL (1993) Comparison of lipid fatty acids on a concentration basis versus weight percentage basis in patients with and without coronary artery disease or diabetes. Clin Chem 39(4):659–663 Schwertner HA, Mosser EL (1993) Comparison of lipid fatty acids on a concentration basis versus weight percentage basis in patients with and without coronary artery disease or diabetes. Clin Chem 39(4):659–663
11.
Zurück zum Zitat Tuna N, Frankhauser S, Goetz FC (1968) Total serum fatty acids in diabetes: relative and absolute concentrations of individual fatty acids. Am J Med Sci 255:120–131CrossRef Tuna N, Frankhauser S, Goetz FC (1968) Total serum fatty acids in diabetes: relative and absolute concentrations of individual fatty acids. Am J Med Sci 255:120–131CrossRef
12.
Zurück zum Zitat Sergeant S, Ruczinski I, Ivester P, Lee TC, Morgan TM, Nicklas BJ, Mathias RA, Chilton FH (2016) Impact of methods used to express levels of circulating fatty acids on the degree and direction of associations with blood lipids in humans. Br J Nutr 115(2):251–261. doi:10.1017/s0007114515004341 CrossRef Sergeant S, Ruczinski I, Ivester P, Lee TC, Morgan TM, Nicklas BJ, Mathias RA, Chilton FH (2016) Impact of methods used to express levels of circulating fatty acids on the degree and direction of associations with blood lipids in humans. Br J Nutr 115(2):251–261. doi:10.​1017/​s000711451500434​1 CrossRef
13.
Zurück zum Zitat Assies J, Pouwer F, Lok A, Mocking RJ, Bockting CL, Visser I, Abeling NG, Duran M, Schene AH (2010) Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study. PLoS ONE 5(5):e10635. doi:10.1371/journal.pone.0010635 CrossRef Assies J, Pouwer F, Lok A, Mocking RJ, Bockting CL, Visser I, Abeling NG, Duran M, Schene AH (2010) Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study. PLoS ONE 5(5):e10635. doi:10.​1371/​journal.​pone.​0010635 CrossRef
14.
Zurück zum Zitat Bradbury KE, Skeaff CM, Green TJ, Gray AR, Crowe FL (2010) The serum fatty acids myristic acid and linoleic acid are better predictors of serum cholesterol concentrations when measured as molecular percentages rather than as absolute concentrations. Am J Clin Nutr 91(2):398–405. doi:10.3945/ajcn.2009.28159 CrossRef Bradbury KE, Skeaff CM, Green TJ, Gray AR, Crowe FL (2010) The serum fatty acids myristic acid and linoleic acid are better predictors of serum cholesterol concentrations when measured as molecular percentages rather than as absolute concentrations. Am J Clin Nutr 91(2):398–405. doi:10.​3945/​ajcn.​2009.​28159 CrossRef
15.
Zurück zum Zitat Mocking RT, Assies J, Lok A, Ruhé H, Koeter MJ, Visser I, Bockting CH, Schene A (2012) Statistical methodological issues in handling of fatty acid data: percentage or concentration, imputation and indices. Lipids 47(5):541–547. doi:10.1007/s11745-012-3665-2 CrossRef Mocking RT, Assies J, Lok A, Ruhé H, Koeter MJ, Visser I, Bockting CH, Schene A (2012) Statistical methodological issues in handling of fatty acid data: percentage or concentration, imputation and indices. Lipids 47(5):541–547. doi:10.​1007/​s11745-012-3665-2 CrossRef
16.
Zurück zum Zitat Abdelmagid SA, Clarke SE, Nielsen DE, Badawi A, El-Sohemy A, Mutch DM, Ma DWL (2015) Comprehensive profiling of plasma fatty acid concentrations in young healthy Canadian adults. PLoS ONE 10(2):e0116195. doi:10.1371/journal.pone.0116195 CrossRef Abdelmagid SA, Clarke SE, Nielsen DE, Badawi A, El-Sohemy A, Mutch DM, Ma DWL (2015) Comprehensive profiling of plasma fatty acid concentrations in young healthy Canadian adults. PLoS ONE 10(2):e0116195. doi:10.​1371/​journal.​pone.​0116195 CrossRef
19.
Zurück zum Zitat McCulloch M, Alvarez E, Gendreau R, Haney S, Harrelson J, Luo R (2014) RE: serum phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst. doi:10.1093/jnci/dju024 McCulloch M, Alvarez E, Gendreau R, Haney S, Harrelson J, Luo R (2014) RE: serum phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst. doi:10.​1093/​jnci/​dju024
20.
Zurück zum Zitat Green A, Battistutta D, Hart V, Leslie D, Marks G, Williams G, Gaffney P, Parsons P, Hirst L, Frost C, Orrell E, Durham K, Lang C (1994) The Nambour skin cancer and actinic eye disease prevention trial: design and baseline characteristics of participants. Control Clin Trials 15(6):512–522. doi:10.1016/0197-2456(94)90008-6 CrossRef Green A, Battistutta D, Hart V, Leslie D, Marks G, Williams G, Gaffney P, Parsons P, Hirst L, Frost C, Orrell E, Durham K, Lang C (1994) The Nambour skin cancer and actinic eye disease prevention trial: design and baseline characteristics of participants. Control Clin Trials 15(6):512–522. doi:10.​1016/​0197-2456(94)90008-6 CrossRef
21.
Zurück zum Zitat Green A, Williams G, Nèale R, Hart V, Leslie D, Parsons P, Marks GC, Gaffney P, Battistutta D, Frost C, Lang C, Russell A (1999) Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 354(9180):723–729CrossRef Green A, Williams G, Nèale R, Hart V, Leslie D, Parsons P, Marks GC, Gaffney P, Battistutta D, Frost C, Lang C, Russell A (1999) Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 354(9180):723–729CrossRef
22.
Zurück zum Zitat Marks GC, Hughes MC, van der Pols JC (2006) Relative validity of food intake estimates using a food frequency questionnaire is associated with sex, age, and other personal characteristics. J Nutr 136(2):459–465CrossRef Marks GC, Hughes MC, van der Pols JC (2006) Relative validity of food intake estimates using a food frequency questionnaire is associated with sex, age, and other personal characteristics. J Nutr 136(2):459–465CrossRef
23.
Zurück zum Zitat Mantzioris E, Cleland LG, Gibson RA, Neumann MA, Demasi M, James MJ (2000) Biochemical effects of a diet containing foods enriched with n-3 fatty acids. Am J Clin Nutr 72(1):42–48CrossRef Mantzioris E, Cleland LG, Gibson RA, Neumann MA, Demasi M, James MJ (2000) Biochemical effects of a diet containing foods enriched with n-3 fatty acids. Am J Clin Nutr 72(1):42–48CrossRef
24.
Zurück zum Zitat Lohner S, Fekete K, Marosvölgyi T, Decsi T (2013) Gender differences in the long-chain polyunsaturated fatty acid status: systematic review of 51 publications. Ann Nutr Metab 62(2):98–112CrossRef Lohner S, Fekete K, Marosvölgyi T, Decsi T (2013) Gender differences in the long-chain polyunsaturated fatty acid status: systematic review of 51 publications. Ann Nutr Metab 62(2):98–112CrossRef
25.
Zurück zum Zitat Khaw K-T, Friesen MD, Riboli E, Luben R, Wareham N (2012) Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study. PLoS Med 9(7):e1001255. doi:10.1371/journal.pmed.1001255 CrossRef Khaw K-T, Friesen MD, Riboli E, Luben R, Wareham N (2012) Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study. PLoS Med 9(7):e1001255. doi:10.​1371/​journal.​pmed.​1001255 CrossRef
26.
Zurück zum Zitat McNaughton SA, Hughes MC, Marks GC (2007) Validation of a FFQ to estimate the intake of PUFA using plasma phospholipid fatty acids and weighed foods records. Br J Nutr 97(3):561–568. doi:10.1017/s0007114507381385 CrossRef McNaughton SA, Hughes MC, Marks GC (2007) Validation of a FFQ to estimate the intake of PUFA using plasma phospholipid fatty acids and weighed foods records. Br J Nutr 97(3):561–568. doi:10.​1017/​s000711450738138​5 CrossRef
27.
Zurück zum Zitat Langsted A, Freiberg JJ, Nordestgaard BG (2008) Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 118(20):2047–2056. doi:10.1161/circulationaha.108.804146 CrossRef Langsted A, Freiberg JJ, Nordestgaard BG (2008) Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 118(20):2047–2056. doi:10.​1161/​circulationaha.​108.​804146 CrossRef
28.
Zurück zum Zitat Nordestgaard BG, Langsted A, Mora S, Kolovou G, Baum H, Bruckert E, Watts GF, Sypniewska G, Wiklund O, Boren J, Chapman MJ, Cobbaert C, Descamps OS, von Eckardstein A, Kamstrup PR, Pulkki K, Kronenberg F, Remaley AT, Rifai N, Ros E, Langlois M (2016) Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J 37(25):1944–1958. doi:10.1093/eurheartj/ehw152 CrossRef Nordestgaard BG, Langsted A, Mora S, Kolovou G, Baum H, Bruckert E, Watts GF, Sypniewska G, Wiklund O, Boren J, Chapman MJ, Cobbaert C, Descamps OS, von Eckardstein A, Kamstrup PR, Pulkki K, Kronenberg F, Remaley AT, Rifai N, Ros E, Langlois M (2016) Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J 37(25):1944–1958. doi:10.​1093/​eurheartj/​ehw152 CrossRef
29.
Zurück zum Zitat Hjartaker A, Lund E, Bjerve KS (1997) Serum phospholipid fatty acid composition and habitual intake of marine foods registered by a semi-quantitative food frequency questionnaire. Eur J Clin Nutr 51(11):736–742CrossRef Hjartaker A, Lund E, Bjerve KS (1997) Serum phospholipid fatty acid composition and habitual intake of marine foods registered by a semi-quantitative food frequency questionnaire. Eur J Clin Nutr 51(11):736–742CrossRef
Metadaten
Titel
Absolute versus relative measures of plasma fatty acids and health outcomes: example of phospholipid omega-3 and omega-6 fatty acids and all-cause mortality in women
verfasst von
Kyoko Miura
Maria Celia B. Hughes
Jacobus P. J. Ungerer
David D. Smith
Adèle C. Green
Publikationsdatum
19.12.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 2/2018
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-016-1358-y

Weitere Artikel der Ausgabe 2/2018

European Journal of Nutrition 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.